Brief: Maravai Lifesciences Holdings Inc- Targeting $700M In Revenue And > 40% Adjusted EBITDA In 2028
Sept 29 (Reuters) - Maravai LifeSciences Holdings Inc
MRVI.O :
* MARAVAI LIFESCIENCES HOLDINGS INC- TARGETING $700M IN
REVENUE
AND > 40% ADJUSTED EBITDA IN 2028
Source text for Eikon: ID:nGNX5fVj2r
Further company coverage: MRVI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Maravai Lifesciences Holdings
See all newsMaravai LifeSciences Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Maravai LifeSciences Q2 revenue beats estimates on strong TriLink demand
Maravai LifeSciences Holdings Inc expected to post a loss of 4 cents a share - Earnings Preview
Maravai LifeSciences Q1 revenue rises on higher CleanCap sales
Brief: Maravai LifeSciences Q1 Revenue USD 65.8 Million Vs. IBES Estimate USD 53 Million